Marimed (MRMD) Interest & Investment Income (2018 - 2026)
Marimed's (MRMD) quarterly Interest & Investment Income came in at $36000.0 in Q1 2026, up 50.0% year-on-year from $24000.0 in Q1 2025, and down 65.05% on a QoQ basis from $103000.0 in Q4 2025.
Marimed (MRMD) Interest & Investment Income (2018 - 2026) Analysis & Trends
Marimed (MRMD) has 9 years of Interest & Investment Income data on file, last reported at $36000.0 in Q1 2026.
- On a quarterly basis, Interest & Investment Income rose 50.0% year-over-year to $36000.0 in Q1 2026; TTM through Mar 2026 was $189000.0, a 68.75% increase from a year earlier, with the FY2025 full-year figure at $177000.0, up 55.26% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $36000.0, down from $103000.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for MRMD reached as high as $318000.0 in Q2 2022 and fell as low as $24000.0 in Q1 2025.
- Historically, Interest & Investment Income has averaged $91529.4 across 5 years, with a median of $36000.0 in 2026.
- Across the five-year window, Interest & Investment Income surged 1738.46% in 2022 and slumped 88.7% in 2023, its largest moves.
- Year by year, Interest & Investment Income stood at $239000.0 in 2022, then slumped by 88.7% to $27000.0 in 2023, then soared by 40.74% to $38000.0 in 2024, then jumped by 171.05% to $103000.0 in 2025, then slumped by 65.05% to $36000.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $36000.0 in Q1 2026, $103000.0 in Q4 2025, and $25000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 32.85 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 41.80 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 28.10 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Marimed | 25.72 Mn | 17.78 Mn | 15.28 Mn | 36,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36,000.00 |
| Dec 31, 2025 | 103,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 24,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Jun 30, 2024 | 25,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Dec 31, 2023 | 27,000.00 |
| Sep 30, 2023 | 29,000.00 |
| Jun 30, 2023 | 115,000.00 |
| Mar 31, 2023 | 99,000.00 |
| Dec 31, 2022 | 239,000.00 |
| Sep 30, 2022 | 239,000.00 |
| Jun 30, 2022 | 318,000.00 |
| Mar 31, 2022 | 163,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Sep 30, 2021 | 26,000.00 |
| Jun 30, 2021 | 36,000.00 |